Novocure Insider Sale: A Routine Liquidity Move Amid Oncology Tech Growth
Novocure insider sales are routine tax‑cover moves, not a sign of trouble. Understand how the oncology tech firm’s pipeline and reimbursement strategy drive future value.
4 minutes to read